Skip to main content
SpringerLink
Log in

IL-10 Synergizes with IL-4 and IL-13 in Inhibiting Lysosomal Enzyme Secretion by Human Monocytes and Lamina Propria Mononuclear Cells from Patients with Inflammatory Bowel Disease

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Tissue injury and inflammation in inflammatorybowel disease (IBD) are associated with enhancedmonocytic lysosomal enzyme release. In this study,peripheral monocytes and lamina propria mononuclearcells (LPMNC) were isolated from IBD patients andnormal controls. Cells were stimulated withlipopolysaccharide after treatment with IL-13, IL-4, andIL-10, and enzyme secretion was assessed by using thecorresponding p-nitrophenyl glycosides as substrates.Molecular forms of cathepsin D were examined to describethe mode of enzyme release. IL-10 and IL-4 stronglydown-regulate enzyme secretion in IBD monocytes. IBD monocytes showed a diminished responsiveness tothe inhibitory effect of IL-13. Impaired monocyteresponse was not found with combinations of IL-13 andIL-10 or IL-4 and IL-10. LPMNC from involved IBD mucosa showed significantly higher enzyme secretioncompared with LPMNC from noninvolved IBD mucosa butresponded inefficiently to either IL-4, IL-13, or IL-10alone. However, combined treatment with IL-10 and IL-4 or IL-10 and IL-13 strongly suppressedenzyme release by these cells. Both the precursor andmature forms of cathepsin D were elevated in IBDpatients. While IL-13 reduced mainly the precursor form, the effect of IL-4 and IL-10 concerns both theprecursor and mature form of cathepsin D. Our resultsfavor the potent clinical utility of combined treatment,thus improving chances of developing effective treatments for human IBD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Mahida YR, Wu K, Jewell DP: Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn' s disease. Gut 30:835 - 838,1989

    Google Scholar 

  2. Hermanowics A, Gibson PR, Jewell DP: The role of phagocytes in inflammatory bowel disease. Clin Sci 69:241 - 249, 1985

    Google Scholar 

  3. Miura M, Hiwatashi N: Impaired monocyte macrophage s function in patients with Crohn's disease. J Clin Lab Immunol 24:167 - 170, 1987

    Google Scholar 

  4. Mahida YR, Wu K, Jewell DP: Respiratory burst activity of intestinal macrophages in normal and infl ammatory bowel disease. Gut 30:1362 - 1370, 1989

    Google Scholar 

  5. Rugtveit J, Haraldsen G, Hogasen AK, Bakka A, Brandzaeg P, Scott H: Respiratory burst of intestinal macrophage s in inflammatory bowel disease is mainly cause d by CD14+L1+ monocyte ce lls. Gut 37:367 - 373, 1995

    Google Scholar 

  6. Schreiber S, MacDe rmott RP, Raedler A, Pinnau R, Bertowich M, Nash GS: Increased activation of intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology 101:1020 - 1030, 1991

    Google Scholar 

  7. Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H: Incre ased macrophage subset in inflammatory bowel disease: Apparent recruitment from peripheral blood monocytes. Gut 35:669 - 674, 1994

    Google Scholar 

  8. Williams JG, Hughes LE, Hallett MB: Toxic oxygen metabolite production by circulating phagocytic ce lls in inflammatory bowel disease. Gut 31:187 - 193, 1990

    Google Scholar 

  9. Ganguly N, Lloyd B, Price C, Kingham J, Lloyd R, Triger D: Acid hydrolases in monocytes from patients with inflammatory bowel disease, chronic liver disease, and rheumatoid arthritis. Lance t, i, 1073 - 1075, 1978

    Google Scholar 

  10. Mee AS, Jewell DP: Monocyte s in inflammatory bowel disease: Monocyte and se rum lysosomal enzyme activity. Clin Sci 58:295 - 300, 1980

    Google Scholar 

  11. Mee AS, Nuttall L, Potter BJ, Jewell DP: Studies on monocytes in inflammatory bowel disease: Factors influencing monocyte lysosomal enzyme activity. Clin Exp Immunol 39:785 - 791, 1980

    Google Scholar 

  12. Scapa E, Neuman M, Eshchar J: In flammatory bowel disease and serum beta-N-ace tylhexosaminidase. Enzyme 43:146 - 150, 1990

    Google Scholar 

  13. Lügering N, Stoll R, Siekmann A, Faulhabe r J, He ese C, Dietrich O, Kucharzik T, Busch H, Hasilik A, Domschke W: Elevated levels of activities of beta-hexosaminidase and alphamannosidase in human immunodeficiency virus-infected patients. J Infect Dis 171:683 - 686, 1995

    Google Scholar 

  14. Kornfeld S: Traffi cking of lysosomal enzyme s in normal and disease states. J Clin Invest 77:1 - 6, 1986

    Google Scholar 

  15. Hasilik A, Neufe ld EF: Biosynthesis of lysosomal enzymes in fi broblasts. Synthesis as precursors of higher molecular weight. J Biol Chem 255:4937 - 4945, 1980

    Google Scholar 

  16. Imort M, Hasilik A, von Figura K: Molecular forms of β-hexoaminidase and cathepsin D in serum and urine of healthy controls and patients with elevated activity of lysosomal enzyme s. Biochem J 213:733 - 740, 1983

    Google Scholar 

  17. Bogdan C, Nathan C: Modulation and macrophage function by transforming growth factor beta, interleukin-4 and interleukin-10. Ann NY Acad Sci 685:713 - 739, 1993

    Google Scholar 

  18. Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD, Raedle r A: Impaired re sponse of activated mononuclear phagocyte s to interleukin 4 in infl ammatory bowel disease. Gastroenterology 108:21 - 33, 1995

    Google Scholar 

  19. De Waal Male fyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by human monocyte s, J. Exp Med 174: 1209 - 1220, 1991 synthesis by human monocytes: An autoregulatory role of IL-10 produced by human monocyte s. J Exp Med 174:1209 - 1220, 1991

    Google Scholar 

  20. Schreiber S, Heinig T, Thiele HG, Raedle r A: Immunoregulatory role of interleukin 10 in patients with in¯ ammatory bowel disease. Gastroenterology 108:1434 - 1444, 1995

    Google Scholar 

  21. Kucharzik T, Lüge ring N, We igelt H, Adolf M, Domschke W, Stoll R: Immunoregulatory properties of Interleukin-13 in patients with inflammatory bowel disease. Comparison with interleukin-4 and interleukin-10. Clin Exp Immunol 104:483 - 490, 1996

    Google Scholar 

  22. Minty A, Chalon P, Derocq J, Dumont X, Guillemot JC, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Case llas P, Loison G, Lupker J, Shire D, Fe rrara P, Caput D: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362:248 - 250, 1993

    Google Scholar 

  23. de Waal, Malefyt R, Figdor CG, Huijbens R, Mohan Peterson S, Bennett B, Culpepper J, Dang W, Zurawsky G, de Vries JE: Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation with IFN-g or IL-10. J Immunol 151:6370 - 6381, 1993

    Google Scholar 

  24. D'Andrea A, Ma X, Aste-Ame zaga M, Paganin C, Trinchieri G: Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononucle ar ce lls: Priming for IL-12 and tumor necrosis factor-a production. J Exp Med 181:537 - 546, 1995

    Google Scholar 

  25. Best WR, Becktel JM, Singleton JW, Ke rn FR: De velopment of a Crohn's disease activity index: National cooperative Crohn's disease study. Gastroente rology 106:782 - 785, 1976

    Google Scholar 

  26. Rachmilewitz D: Coated mesalazine (5-amino-salicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomized trial. Br Med J 198:82 - 86, 1989

    Google Scholar 

  27. Re inecker HC, Steffen M, Witthoeft T, Pflueger I, Schre iber S, MacDe rmott RP, Raedler A: Enhanced se cre tion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94:174 - 181, 1993

    Google Scholar 

  28. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680 - 685, 1970

    Google Scholar 

  29. Towbin H, Staehelin T, Gordon J: Electrophore tic transfer of proteins from polyacrylamide ge ls to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350 - 4354, 1979

    Google Scholar 

  30. Kucharzik T, Lügering N, Adolf M, Domschke W, Stoll R: Syne rgistic effect of immunoregulatory cytokines on peripheral blood monocyte s from patients with infl ammatory bowel disease Dig Dis Sci 42:805 - 812, 1997

    Google Scholar 

  31. Lügering N, Kucharzik T, Lügering A, Winde G, Domschke W, Stoll R: Importance of combined treatment with IL-10 and IL-4, but not IL-13, for inhibiting monocyte re lease of the Ca2+binding protein MRP8/14. Immunology 91:130 - 134, 1997

    Google Scholar 

  32. Mahida YR, Pate l S, Gionchetti P, Vaux D, Jewell DP: Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. Gut 30:826 - 834, 1989

    Google Scholar 

  33. Cappe llo M, Keshav S, Prince C, Jewell DP, Gordon S: Detection of mRNAs for macrophage products in inflammatory bowel disease by in situhybridisation. Gut 33:1214 - 1219, 1992

    Google Scholar 

  34. Endo T, Fumitaka O, Sone S: LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-g. J Immunol 156:2240 - 2246, 1996

    Google Scholar 

  35. Hart PH, Ahern MJ, Smith MD, Finlay-Jone s JJ: Regulatory effects of IL-13 on synovial fluid macrophages and blood monocyte s from patients with inflammatory arthritis. Clin Exp Immunol 99:331 - 339, 1995

    Google Scholar 

  36. Zurawski G, De Vries JE: Interleukin-13, an interleukin-4 like cytokine that acts on monocyte s and B ce lls, but not on T-ce lls. Immunol Today 15:19 - 26, 1994

    Google Scholar 

  37. Nakagawara A, Nathan CF, Cohn ZA: Hydrogen peroxide me tabolism in human monocytes during differentiation in vitro. J Clin Invest 68:1243 - 1252, 1981

    Google Scholar 

  38. Baldassano RN, Schreiber S, Johnston RB, Muraki T, MacDermott RP: Monocyte s of patients with Crohn's disease are primed for accentuate d rele ase of toxic oxyge n metabolite s: Possible role for endotoxin. Gastroente rology 105:60 - 66, 1993

    Google Scholar 

Download references

Authors
  1. Norbert Lugering
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Torsten Kucharzik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Henning Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gunther Winde
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andreas Lugering
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Andrej Hasilik
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wolfram Domschke
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Reinhard Stoll
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lugering, N., Kucharzik, T., Stein, H. et al. IL-10 Synergizes with IL-4 and IL-13 in Inhibiting Lysosomal Enzyme Secretion by Human Monocytes and Lamina Propria Mononuclear Cells from Patients with Inflammatory Bowel Disease. Dig Dis Sci 43, 706–714 (1998). https://doi.org/10.1023/A:1018845526434

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018845526434

Search

Navigation